MYAM
UTHR icon

Meiji Yasuda Asset Management’s United Therapeutics UTHR Stock Holding History

Meiji Yasuda Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.41M Buy
9,979
+1,423
+17% +$801K 0.24% 130
2026
Q1 		$5.07M Buy
8,556
+2,965
+53% +$1.48M 0.25% 122
2025
Q4 		$2.72M Buy
5,591
+4,317
+339% +$2.01M 0.13% 183
2025
Q3 		$534K Sell
1,274
-160
-11% -$53.8K 0.03% 322
2025
Q2 		$412K Sell
1,434
-527
-27% -$157K 0.02% 369
2025
Q1 		$605K Sell
1,961
-19
-1% -$6.51K 0.02% 396
2024
Q4 		$699K Sell
1,980
-12
-0.6% -$4.41K 0.03% 372
2024
Q3 		$714K Sell
1,992
-55
-3% -$18.6K 0.03% 359
2024
Q2 		$652K Buy
2,047
+33
+2% +$8.73K 0.03% 370
2024
Q1 		$463K Buy
2,014
+378
+23% +$85.3K 0.02% 447
2023
Q4 		$360K Buy
1,636
+80
+5% +$18.4K 0.02% 443
2023
Q3 		$351K Buy
+1,556
New +$358K 0.02% 496
2019
Q1 		– Sell
-2,000
Closed -$218K – 476
2018
Q4 		$218K Sell
2,000
-400
-17% -$46.4K 0.02% 440
2018
Q3 		$307K Buy
2,400
+200
+9% +$24.7K 0.03% 430
2018
Q2 		$249K Hold
2,200
– – 0.02% 451
2018
Q1 		$247K Hold
2,200
– – 0.02% 455
2017
Q4 		$325K Buy
2,200
+210
+11% +$26.7K 0.03% 431
2017
Q3 		$233K Buy
+1,990
New +$254K 0.02% 464
2017
Q2 		– Sell
-2,890
Closed -$391K – 507
2017
Q1 		$391K Sell
2,890
-300
-9% -$45.4K 0.04% 392
2016
Q4 		$458K Sell
3,190
-100
-3% -$12.8K 0.05% 352
2016
Q3 		$388K Buy
3,290
+460
+16% +$55.3K 0.05% 362
2016
Q2 		$300K Buy
2,830
+290
+11% +$32.3K 0.04% 366
2016
Q1 		$283K Buy
2,540
+250
+11% +$31.6K 0.06% 280
2015
Q4 		$359K Buy
+2,290
New +$333K 0.08% 242

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Meiji Yasuda Asset Management's UTHR Position: Q2 2026 in Review

Meiji Yasuda Asset Management increased its United Therapeutics (UTHR) stake by 17% in Q2 2026, buying an estimated $801K and bringing the position to 9,979 shares worth $5.41M. The position accounts for 0.24% of the portfolio, ranked #130.

Meiji Yasuda Asset Management first reported a position in UTHR in Q4 2015 and has held it in 24 quarters since. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Meiji Yasuda Asset Management held 9,979 shares of United Therapeutics worth $5.41M as of Q2 2026.
  • Meiji Yasuda Asset Management bought 1,423 United Therapeutics shares in Q2 2026, an estimated $801K.
  • United Therapeutics made up 0.24% of Meiji Yasuda Asset Management's portfolio in Q2 2026, its #130 holding.
  • Meiji Yasuda Asset Management first reported a position in United Therapeutics in Q4 2015 and has held it in 24 quarters since.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Meiji Yasuda Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.